MyFinsight
Home
Blog
About
Net loss
attributable to adaptive...
-$39,788K
(-55.34%↓ Y/Y)
Add net loss
(income) attributable to...
-$153K
(-828.57%↓ Y/Y)
Service
$66,168K
(48.90%↑ Y/Y)
Revenue From Contract
With Customer...
$5,385K
Net loss
-$39,941K
(-56.06%↓ Y/Y)
Interest and other
income, net
$2,256K
(-5.65%↓ Y/Y)
MRDRevenue
$66,168K
(32.50%↑ Y/Y)
Immune Medicine
Revenue
$5,385K
(-39.77%↓ Y/Y)
Loss on revenue
interest liability...
$23,733K
Loss from operations
-$15,770K
(37.01%↑ Y/Y)
Interest expense
$2,694K
(-8.62%↓ Y/Y)
Revenue
$71,553K
(21.53%↑ Y/Y)
Total operating
expenses
$87,323K
(4.06%↑ Y/Y)
Sales and marketing
$26,414K
(12.05%↑ Y/Y)
General and
administrative
$21,168K
(19.01%↑ Y/Y)
Cost of revenue
$20,165K
(12.03%↑ Y/Y)
Research and development
$19,153K
(-20.64%↓ Y/Y)
Amortization of intangible
assets
$423K
(0.00%↑ Y/Y)
Back
Back
Income Statement
Adaptive Biotechnologies Corp (ADPT)
Adaptive Biotechnologies Corp (ADPT)
source: myfinsight.com